1. Home
  2. HLX vs OGN Comparison

HLX vs OGN Comparison

Compare HLX & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helix Energy Solutions Group Inc.

HLX

Helix Energy Solutions Group Inc.

N/A

Current Price

$9.80

Market Cap

1.4B

Sector

Energy

ML Signal

N/A

Logo Organon & Co.

OGN

Organon & Co.

N/A

Current Price

$13.53

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HLX
OGN
Founded
1979
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
HLX
OGN
Price
$9.80
$13.53
Analyst Decision
Strong Buy
Hold
Analyst Count
2
5
Target Price
$11.50
$11.40
AVG Volume (30 Days)
1.2M
2.5M
Earning Date
04-22-2026
05-07-2026
Dividend Yield
N/A
0.60%
EPS Growth
N/A
N/A
EPS
N/A
0.55
Revenue
$876,561,000.00
$6,216,000,000.00
Revenue This Year
$2.05
$0.45
Revenue Next Year
$5.46
$1.67
P/E Ratio
N/A
$24.58
Revenue Growth
3.60
N/A
52 Week Low
$5.58
$5.69
52 Week High
$10.75
$13.60

Technical Indicators

Market Signals
Indicator
HLX
OGN
Relative Strength Index (RSI) 63.20 60.43
Support Level $9.21 $13.46
Resistance Level $9.89 $13.60
Average True Range (ATR) 0.28 0.03
MACD 0.09 -0.02
Stochastic Oscillator 92.16 54.17

Price Performance

Historical Comparison
HLX
OGN

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. The Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S., and it also has its presence in North Sea, Brazil, Asia Pacific, West Africa, and Other.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: